Search results
AbbVie Inc. (NYSE:ABBV) Shares Bought by Bell Investment Advisors Inc
ETF DAILY NEWS· 20 hours agoBell Investment Advisors Inc lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 6.6% during the 4th quarter, according to its most recent disclosure ...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 days agoAbbVie is graded C on this front, indicating that it is trading at par with its peers. Click here to...
AbbVie Inc. (NYSE:ABBV) Holdings Lowered by Westwood Holdings Group Inc.
ETF DAILY NEWS· 4 days agoWestwood Holdings Group Inc. lessened its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the fourth quarter, Holdings Channel.com reports. The fund ...
Mosley Wealth Management Invests $605,000 in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoMosley Wealth Management purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased ...
CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into...
Benzinga· 6 days agoNEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) and AbbVie, Inc. If you invested in
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoNEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie ...
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 2 days agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 7 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...